Beside Troponin in the case of acute coronary syndrome [28], BNP is one of the most interesting biomarkers to grade the extent of heart failure to support medical decisions making and to monitor responses to therapy [29], [30]. This evidence concerns the gene NPPB and acute coronary syndrome.